Package 0002-8905-11

Brand: taltz

Generic: ixekizumab
NDC Package

Package Facts

Identity

Package NDC 0002-8905-11
Digits Only 0002890511
Product NDC 0002-8905
Product ID 0002-8905_246fceb3-0f60-4bd7-8f06-4f34537f5d95
Description

1 SYRINGE in 1 CARTON (0002-8905-11) / 1 mL in 1 SYRINGE (0002-8905-01)

Marketing

Marketing Status
Marketed Since 2024-02-02
Brand taltz
Generic ixekizumab
Sample Package No

Linked Drug Pages (1)

TALTZ ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "246fceb3-0f60-4bd7-8f06-4f34537f5d95", "openfda": {"nui": ["N0000191495", "N0000191494"], "unii": ["BTY153760O"], "rxcui": ["1745103", "1745108", "1745112", "1745114", "2674931", "2674932", "2674933", "2674934"], "spl_set_id": ["ac96658a-d7dc-4c7c-8928-2adcdf4318b2"], "pharm_class_epc": ["Interleukin-17A Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-17A Antagonists [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (0002-8905-11)  / 1 mL in 1 SYRINGE (0002-8905-01)", "package_ndc": "0002-8905-11", "marketing_start_date": "20240202"}], "brand_name": "TALTZ", "product_id": "0002-8905_246fceb3-0f60-4bd7-8f06-4f34537f5d95", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin-17A Antagonist [EPC]", "Interleukin-17A Antagonists [MoA]"], "product_ndc": "0002-8905", "generic_name": "ixekizumab", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TALTZ", "active_ingredients": [{"name": "IXEKIZUMAB", "strength": "40 mg/.5mL"}], "application_number": "BLA125521", "marketing_category": "BLA", "marketing_start_date": "20160322", "listing_expiration_date": "20261231"}